Xie, X., Lv, J., Zhu, W., Tian, C., Li, J., Liu, J., . . . Li, X. (2022). The combination therapy of oncolytic HSV-1 armed with anti-PD-1 antibody and IL-12 enhances anti-tumor efficacy. Elsevier.
Style de citation Chicago (17e éd.)Xie, Xin, et al. The Combination Therapy of Oncolytic HSV-1 Armed with Anti-PD-1 Antibody and IL-12 Enhances Anti-tumor Efficacy. Elsevier, 2022.
Style de citation MLA (8e éd.)Xie, Xin, et al. The Combination Therapy of Oncolytic HSV-1 Armed with Anti-PD-1 Antibody and IL-12 Enhances Anti-tumor Efficacy. Elsevier, 2022.
Attention : ces citations peuvent ne pas être correctes à 100%.